Display Accessibility Tools

Accessibility Tools

Grayscale

Highlight Links

Change Contrast

Increase Text Size

Increase Letter Spacing

Readability Bar

Dyslexia Friendly Font

Increase Cursor Size

Current Research

Synthetic Biology in Plant Natural Compounds

The best chemists are green. We focus on discovery of plant pathways for bioactive diterpenoids found in medicinal plant species. The functional parts allow the engineering of biotechnological chassis systems for biosustainable production.


Terpenoids (isoprenoids) are the largest and most ancient class of specialized metabolites on the planet. An amazing structural diversity reflects many biological functions that evolution has spawned. Diterpenoids, with their twenty-carbon backbone, constitute roughly a fourth of all known plant terpenoids, which currently are represented by more than 12,000 (and counting) known structures.

With only one notable exception all plants need the diterpenoid phytohormone gibberellic acid for growth and development (general metabolism). A few plant species have evolved to produce highly specialized, sometimes unique bioactive diterpenes, with important roles in plant defense. For humans, these plants are recognized since ancient times in traditional medicine, and as flavors and fragrances. More recently, diterpenoids extracted from their plant source are exploited for their analgesic, flavoring, antimicrobial, antifungal, contraceptive and psychoactive properties, and other potential industrial applications. Prominent examples of high-value plant based pharmaceuticals are the diterpenoids forskolin and ingenol-3-angelate, molecules for treatment of heart failure and skin conditions leading to cancer.


industrial applications

Despite the high commercial potential, industrial applications for diterpenoids are limited for a number of reasons: low amounts accumulating in the native plants, challenges with cultivation, harvest, extraction and purification of the target compound, often only a fraction of a mixture of related, but undesired compounds. In addition, chemical synthesis is currently economically not feasible due to the structural complexity.

The discovery and transfer of the biosynthetic routes from the native plant species is critical for engineering of biotechnological production hosts for biosustainable production. We have recently targeted 10 medicinal plant species accumulating structurally unique diterpenoids and discovered a dazzling rich repertoire of the biosynthetic enzymes [Zerbe, Hamberger et al., 2013]. Our aim is to establish, with those enzymes, sustainable platforms for production of plant-derived specialized metabolites, "cellular factories", with focus on bioactive pharmaceuticals or nutraceuticals with highly complex structure and stereochemistry belonging to the diterpenoid (C-20) class of compounds.

Diterpenoids are structurally highly complex, but the biosynthetic routes are relatively simple: only two enzyme families are involved in the key steps. Geranylgeranyl-diphosphate (GGPP), the ubiquitous C-20 precursor for all diterpene biosynthesis is cyclized by diterpene synthases (diTPS).  The resulting diterpenes are further functionalized by enzymes of the cytochrome P450 mono-oxygenase class (P450), drivers of chemical diversification [Hamberger and Bak, 2013].


biosynthetic routes
Simple pathways to complex natural products: diterpenoid biosynthesis through enzymes of the diterpene synthase family and their functionalization by cytochromes P40.

We recently discovered the first steps of the pathway to forskolin in a single cell-type of the medicinal plant Coleus forskohlii, where the high-value diterpenoids accumulate in lipid bodies [Pateraki, Andersen Ranberg et al., 2014].


forskolin-biosynthesis

Forskolin biosynthesis in Coleus forskohlii. A. Lipid bodies are found in a cell-type of the outer root cork and Nile red staining shows a heterogeneous lipid composition in green and red. B. (13R) manoyl oxide, precursor of forskolin is detected in purified lipid bodies. C. Schematic localization of the biosynthetic route to forskolin starting in plastids, with oxidative decoration happening at the endoplasmatic reticulum and storage of diterpenes in lipid bodies.


Discovery of the functional parts from diverse plant species has opened the door to combinatorial biosynthesis: we have recently succeeded in building several neo-natural pathways by pairing enzymes in novel combinations [Andersen Ranberg et al., 2016].

 

Selected publications

High-level production of target diterpenoids in metabolically engineered moss


tissue culture

Transfer of the biosynthetic steps from the original species into the moss Physcomitrella patens holds a high potential for production of targeted diterpenoids for a number of reasons. Similar to commonly used microbes P. patens can be grown in large fermenter scale. As a photosynthetic organism, P. patens does not require sugar as carbon source for metabolite production, sunlight and atmospheric carbon dioxide are sufficient.

While P. patens lacks GA diterpenoid phytohormones, essential in all other plants for growth and development, early intermediates are produced in substantial amounts. The committed biosynthetic step in endogenous moss diterpenoid production, catalyzed by ent-kaurene synthase (PpEKS) has been identified and the encoding gene has been disrupted, resulting in viable lines without detectable diterpenoid background. These knock-out lines have an imminent capacity for production of foreign diterpenes using diTPS from other plant species as demonstrated in a pilot study using the bifunctional conifer diterpene synthase PaLAS. With this system we are approaching one of the main limitations in metabolic engineering of terpenoid pathways: functional expression of P450s, membrane bound enzymes typically located to the ER of the plant cells.

 

Published work

(MSU, see NCBI MyBibliography: https://goo.gl/HLCcf4 for full list)

 

2023

Bibik JD, Hamberger BR (2023) Plant engineering to enable platforms for sustainable bioproduction of terpenoids. Review in: Synthetic Biology (second edition), Springer/Nature, Ed. Jeff Braman (accepted)

Bibik JD, Bryson AE, Hamberger BR (2023) Compartmentalized Terpenoid Production In Plants Using Agrobacterium-mediated Transient Expression. Methods in: Synthetic Biology (second edition), Springer/Nature, Ed. Jeff Braman (2023) (accepted)

Lanier ER, Andersen TB, Hamberger B. Plant terpene specialized metabolism: Complex networks or simple linear pathways? (2023) Plant J. doi: 10.1111/tpj.16177.

Raza S, Miller M, Hamberger B, Vermaas JV. Plant Terpenoid Permeability through Biological Membranes Explored via Molecular Simulations. (2023) J Phys Chem B. 2023;127(5):1144-1157. doi: 10.1021/acs.jpcb.2c07209.

Bryson AE, Lanier ER, Lau KH, Hamilton JP, Vaillancourt B, Mathieu D, Yocca AE, Miller GP, Edger PP, Buell CR, Hamberger B. Uncovering a miltiradiene biosynthetic gene cluster in the Lamiaceae reveals a dynamic evolutionary trajectory. (2023) Nat Commun. 20;14(1):343. doi: 10.1038/s41467-023-35845-1.

 

2022

UG*61. Bibik JD, Weraduwage SM, Banerjee A, Robertson K, Espinoza-Corral R, Sharkey TD, Lundquist PK, Hamberger BR. Pathway Engineering, Re-targeting, and Synthetic Scaffolding Improve the Production of Squalene in Plants. (2022) ACS Synthetic Biology. doi: 10.1021/acssynbio.2c00051 Cover feature.

*60. Ntana F, Johnson SR, Jensen B, Jørgensen HJ, Hamberger B, Collinge DB. Regulation of Tomato Specialised Metabolism after Establishment of Symbiosis with the Endophytic Fungus Serendipita indica. (2022) Microorganisms.; 10(1):194. doi.org/10.3390/microorganisms10010194.

 

2021

Ntana F, Bhat WW, Johnson SR, Jørgensen HJL, Collinge DB, Jensen B, Hamberger B. A Sesquiterpene Synthase from the Endophytic Fungus Serendipita indica Catalyzes Formation of Viridiflorol. (2021) Biomol. 11(6), 898. https://doi.org/10.3390/biom11060898

Brose J, Lau KH, Dang TTT, Hamilton JP, Martins LDV, Hamberger B, Hamberger B, Jiang J, O'Connor SE, Buell CR. The Mitragyna speciosa (Kratom) Genome: A resource for data-mining potent pharmaceuticals that impact human health. (2021) G3 (Bethesda).  doi:10.1093/g3journal/jkab058.

 

2020

Hamberger B, Yuen MM, Buschiazzo E, Cullis C, Yuen A, Ritland C, Bohlmann J, Hamberger B. An Intact, But Dormant LTR Retrotransposon Defines a Moderately Sized Family in White Spruce (Picea glauca). (2020) In: The Spruce Genome. Porth I, De la Torre A, editors. Springer Nature: Springer International Publishing; 2020. Chapter 4; 51-63p.

Miller GP, Bhat WW, Lanier ER, Johnson SR, Mathieu DT, Hamberger B. The biosynthesis of the anti-microbial diterpenoid leubethanol in Leucophyllum frutescens proceeds via an all-cis prenyl intermediate. (2020) Plant J.;104(3):693-705. doi: 10.1111/tpj.14957.

Hamilton JP, Godden GT, Lanier E, Bhat WW, Kinser TJ, Vaillancourt B, Wang H, Wood JC, Jiang J, Soltis PS, Soltis DE, Hamberger B, Buell CR. Generation of a chromosome-scale genome assembly of the insect-repellent terpenoid-producing Lamiaceae species, Callicarpa americana. (2020) Gigascience.;9(9). doi: 10.1093/gigascience/giaa093.

Lau KH, Bhat WW, Hamilton JP, Wood JC, Vaillancourt B, Wiegert-Rininger K, Newton L, Hamberger B, Holmes D, Hamberger B, Buell CR. Genome assembly of Chiococca alba uncovers key enzymes involved in the biosynthesis of unusual terpenoids. (2020) DNA Res.;27(3). doi: 10.1093/dnares/dsaa013.

 

2019

Johnson SR, Bhat WW, Sadre R, Miller GP, Garcia AS, Hamberger B. Promiscuous terpene synthases from Prunella vulgaris highlight the importance of substrate and compartment switching in terpene synthase evolution. (2019) The New Phytologist; doi: 10.1111/nph.15778.
https://facultyopinions.com/prime/735264042

Zhao D, Hamilton JP, Bhat WW, Johnson SR, Godden GT, Kinser TJ, Boachon B, Dudareva N, Soltis DE, Soltis PS, Hamberger B, Buell CR. A chromosomal-scale genome assembly of Tectona grandis reveals the importance of tandem gene duplication and enables discovery of genes in natural product biosynthetic pathways. (2019) Gigascience. doi: 10.1093/gigascience/giz005.

Sadre R, Kuo P, Chen J, Yang Y, Banerjee A, Benning C, Hamberger B. Cytosolic lipid droplets as engineered organelles for production and accumulation of terpenoid biomaterials in leaves. (2019) Nature Communications (2019); doi: 10.1038/s41467-019-08515-4.              https://facultyopinions.com/prime/735120965

Johnson SR, Bhat WW, Bibik J, Turmo A, Hamberger B, Genomics Consortium EM, Hamberger B. A database-driven approach identifies additional diterpene synthase activities in the mint family (Lamiaceae). (2019) J Biol Chem; doi: 10.1074/jbc.RA118.006025

Banerjee A, Arnesen JA, Moser D, Motsa BB, Johnson SR, Hamberger B. Engineering modular diterpene biosynthetic pathways in Physcomitrella patens. (2019) Planta. 249(1):221-233; doi: 10.1007/s00425-018-3053-0

 

2018

UG48. Madsen CS, Barvo NN, Fromwiller C, Tyll S, Amburn B, Ducat D, Hamberger B, TerAvest MA. Current production as a rapid response expression reporter under micro-oxic and anoxic conditions. (2018) bioRxiv, 289140

Banerjee, A. & Hamberger, B. P450s controlling metabolic bifurcations in plant terpene specialized metabolism. (2018) Phytochem Rev; 17(1):81-111. https://doi.org/10.1007/s11101-017-9530-4

 

Patents and Invention Disclosures

TEC2023-0046 Genetically Engineered Cupriavidus necator H16 as a Chassis Host for High-Capacity Carotenoid Production. (2022)
Inventors Aboulnaga E., Hamberger B.

TEC2023-0041 Genetically Engineered E. coli as a Platform for High Yield Terpenoid Production.
Inventors Aboulnaga E., Hamberger B. (2022)

TEC2023-0002PROV 3000.210PRV; PROVISIONAL PATENT APPLICATION (2022)
Production of Diterpene Alkaloids. Inventors Miller G., Pascoe I., Van Winkle K., Hamberger B.

Board of Trustees of Michigan State University Ref. No. TEC2019-0180 - SLW Ref. No. 3000.192PRV U.S. Patent Application Serial No.: 62/899,391 
Title:   METHOD FOR PRODUCING THE SESQUITERPENE VIRIDIFLOROL WITH A FUNGAL ENZYME
Inventors Ntana, Collinge, Hamberger, Bhat, Johnson, Jensen, Jørgensen (January 2020, provisional)

Board of Trustees of Michigan State University Ref. No. TEC2020-0051 - SLW Ref. No. 3000.195PRV U.S. Patent Application Serial No.: 62/930,898 
Title:   BIOSYNTHESIS OF CHEMICALLY DIVERSIFIED NON-NATURAL TERPENE PRODUCTS 
Inventors Ellsworth, Giletto, Hamberger, Miller, Neubig (November 2019, provisional)

Provisional MSU Ref.: TEC2020-0109; "Serrulatane Diterpene" (SLW: 3000.197PRV) Patent Application Serial No.: 62/986,286)
Title: METHOD TO PRODUCE THE ANTI-MICROBIAL DITERPENOID LEUBETHANOL AND RELATED SERRULATANE-TYPE DITERPENES
Inventors Miller, Bhat, Lanier, Johnson, Mathieu and Hamberger (March 2020)

Board of Trustees of Michigan State University Ref. No. TEC2019-0011-01Prov - SLW Ref. No. 3000.182PRV U.S. Patent Application Serial No.: 62/714,216 
Title:   METHOD FOR PRODUCTION OF NOVEL DITERPENE SCAFFOLDS
Inventors Hamberger, Johnson and Bhat (August 2019, International Application (PCT) for filing in the US PCT/US2019/044887)

Board of Trustees of Michigan State University Ref. No. TEC2018-0153-01Prov - SLW Ref. No. 3000.181PRV U.S. Patent Application Serial No.: 62/716,076, European Patent Application No. 19848065.9
Title:   IMPROVED PRODUCTION OF TERPENOIDS USING ENZYMES ANCHORED TO LIPID DROPLET SURFACE PROTEINS
Inventors Hamberger, Bibik, Sadre, Benning (August 2019, International Application (PCT) for filing in the US PCT/US19/45730)